Aβ42 vaccine on the Tg2576 Alzheimer model mice

International Congress Series

Volumn 1252, Issue C, 2003, Pages 399-403

  Shoji, Mikio ^a   Harigaya, Yasuo ^b   Matsubara, Etsuro ^a   Kawarabayashi, Takeshi ^a   Murakami, Tetsuro ^a   Oomori, Nobuhiko ^a   Sato, Keiko ^a   Nagano, Isao ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b MAEBASHI RED CROSS HOSPITAL   (Japan)

Author keywords

Alzheimer's disease; A amyloid; A vaccine; Efficacy; Treatment

Indexed keywords

EID: 77953468393     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(03)00101-8     Document Type: Article

References (12)

1. D. Schenk R. Barbour W. Dunn G. Gordon H. Grajeda T. Guido K. Hu J. Huang K. Johnson-Wood K. Khan D. Kholodenko M. Lee Z. Liao I. Lieberburg R. Motter L. Mutter F. Soriano G. Shopp N. Vasquez C. Vandevert S. Walker M. Wogulis T. Yednock D. Games P. Seubert Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
2. H.L. Weiner C.A. Lemere R. Maron E.T. Spooner T.J. Grenfell C. Mori S. Issazadeh W.W. Hancock D.J. Selkoe Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease Ann. Neurol. 48 2000 567 579
3. C. Janus J. Pearson J. McLaurin P.M. Mathews Y. Jiang S.D. Schmidt M.A. Chishti P. Horne D. Heslin J. French H.T. Mount R.A. Nixon M. Mercken C. Bergeron P.E. Fraser P. St George-Hyslop D. Westaway A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease Nature 408 2000 979 982
4. D. Morgan D.M. Diamond P.E. Gottschall K.E. Ugen C. Dickey J. Hardy K. Duff P. Jantzen G. DiCarlo D. Wilcock K. Connor J. Hatcher C. Hope M. Gordon G.W. Arendash A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408 2000 982 985
5. E.M. Sigurdsson H. Scholtzova P.D. Mehta B. Frangione T. Wisniewski Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice Am. J. Pathol. 159 2 2001, Aug. 439 447
6. P. Das M.P. Murphy L.H. Younkin S.G. Younkin T.E. Golde Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition Neurobiol. Aging 22 2001 721 727
7. F. Bard C. Cannon R. Barbour R.L. Burke D. Games H. Grajeda T. Guido K. Hu J. Huang K. Johnson-Wood K. Khan D. Kholodenko M. Lee I. Lieberburg R. Motter M. Nguyen F. Soriano N. Vasquez K. Weiss B. Welch P. Seubert D. Schenk T. Yednock Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat. Med. 6 8 2000, Aug. 916 919
8. R.B. DeMattos K.R. Bales D.J. Cummins J.C. Dodart S.M. Paul D.M. Holtzman Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 98 15 2001, Jul. 17 8850 8855
9. B.J. Bacskai S.T. Kajdasz R.H. Christie C. Carter D. Games P. Seubert D. Schenk B.T. Hyman Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy Nat. Med. 7 2001 369 372
10. A. Monsonego R. Maron V. Zota D.J. Selkoe H.L. Weiner Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 98 18 2001, Aug. 28 10273 10278
11. Y. Du R. Dodel H. Hampel K. Buerger S. Lin B. Eastwood K. Bales F. Gao H.J. Moeller W. Oertel M. Farlow S. Paul Reduced levels of amyloid beta-peptide antibody in Alzheimer disease Neurology 57 5 2001, Sept. 11 801 805
12. E. Check Nerve inflammation halts trial for Alzheimer's drug Nature 415 2002 462